XML 112 R31.htm IDEA: XBRL DOCUMENT v3.22.2

Stockholders’ Equity (Tables)

6 Months Ended

Jun. 30, 2022

Equity [Abstract]

Schedule of Stockholders' Equity Note, Warrants or Rights

A summary of the Company’s outstanding warrants as of June 30, 2022, are presented below (in thousands, except share and exercise price):

			Number of Shares						Weighted Average Exercise Price						Total Intrinsic Value						Weighted Average Remaining Contractual Life (in years)
Outstanding as of December 31, 2021			565,544						$	9.96					$	3,546					0.1
Exercised			(540,541)						$	9.25					$	—					-
Expired			(25,000)						$	9.25
Outstanding and exercisable as of June 30, 2022			3						$	24,000.00					$	—					0.0

Share-based Payment Arrangement, Expensed and Capitalized, Amount

During the three and six months ended June 30, 2022 and 2021 the Company recognized stock-based compensation expense as follows (in thousands):

			Three Months Ended June 30,												Six Months Ended June 30,
			2022						2021						2022						2021
Subscriber related			$	36					$	16					$	76					$	30
Sales and marketing			4,253						790						13,133						1,503
Technology and development			2,905						8,551						5,589						10,621
General and administrative			7,015						15,074						14,860						21,651
			$	14,209					$	24,431					$	33,658					$	33,805

Share-based Payment Arrangement, Activity

A summary of stock option activity for the six months ended June 30, 2022, is as follows (in thousands, except share and per share amounts):

			Number of Shares						Weighted Average Exercise Price						Total Intrinsic Value						Weighted Average Remaining Contractual Life (Years)
Outstanding as of December 31, 2021			11,454,890						$	6.40					$	70,231					7.4
Exercised			(430,122)						$	1.33
Forfeited or expired			(443,836)						$	10.30
Outstanding as of June 30, 2022			10,580,932						$	6.45					$	4,248					6.5
Options vested and exercisable as of June 30, 2022			7,524,928						$	4.83					$	4,124					5.4

A summary of activity under the 2020 Plan for market and service-based stock options for the six months ended June 30, 2022 is as follows (in thousands, except share and per share amounts):

			Number of Shares						Weighted Average Exercise Price						Total Intrinsic Value						Weighted Average Remaining Contractual Life (Years)
Outstanding as of December 31, 2021			4,453,297						$	12.75					$	17,933					5.7
Outstanding as of June 30, 2022			4,453,297						$	12.75					$	—					5.2
Options vested and exercisable as of June 30, 2022			3,536,630						$	10.98					$	—					5.0

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions

The following was used in determining the fair value of stock options granted during the six months ended June 30, 2021:

						Six months ended June 30,
									2021
Dividend yield									$	—
Expected price volatility									45.04		%
Risk free interest rate									1.0		%
Expected term (years)									6.0

Schedule of Nonvested Restricted Stock Units Activity

A summary of the Company’s time-based restricted stock unit activity during the six months ended June 30, 2022 is as follows:

			Number of Shares						Weighted Average Grant-Date Fair Value
Unvested at December 31, 2021			2,785,800						$	25.73
Granted			3,281,021						$	5.79
Vested			(252,787)						$	26.05
Forfeited			(275,834)						$	19.60
Unvested at June 30, 2022			5,538,200						$	14.21

A summary of the Company’s performance-based restricted stock unit activity during the six months ended June 30, 2022 is as follows:

			Number of Shares						Weighted Average Grant-Date  Fair Value
Unvested at December 31, 2021			1,900,000						$	33.87
Vested			(280,000)						$	33.87
Unvested at June 30, 2022			1,620,000						$	33.87

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration